Dapsone motor neuropathy--an axonal disease

Area of Science:

• Neuroscience
• Toxicology
• Pharmacology

Background:

• Dapsone is a medication used to treat various conditions, including leprosy and dermatitis herpetiformis.
• Neuropathy is a potential side effect of dapsone treatment, characterized by nerve damage.

Observation:

• Dapsone-induced neuropathy predominantly impacts the soma and axons of motor neurons.
• Sensory axon involvement is minimal or absent in most cases.
• Clinical manifestations include distal weakness and muscle wasting, consistent with a 'dying back' phenomenon of motor axons.

Findings:

• The primary pathological effect of dapsone is on motor neuron axons, not myelin.
• Axon regeneration and peripheral sprouting are the mechanisms underlying recovery from dapsone neuropathy.
• Individual susceptibility to dapsone toxicity may be linked to slow dapsone acetylation rates.

Implications:

• Understanding dapsone's neurotoxic mechanism aids in managing patient treatment and monitoring for adverse effects.
• Identifying patients at risk for neuropathy can guide preventative strategies and alternative therapeutic choices.
• Further research into dapsone acetylation pathways could lead to personalized medicine approaches for dapsone therapy.